Linden Thomas Advisory Services LLC Cuts Holdings in Silicon Laboratories, Inc. $SLAB

Linden Thomas Advisory Services LLC decreased its position in Silicon Laboratories, Inc. (NASDAQ:SLAB) by 0.6% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,506 shares of the semiconductor company’s stock after selling 78 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Silicon Laboratories were worth $1,843,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. GAMMA Investing LLC increased its stake in shares of Silicon Laboratories by 99.6% during the first quarter. GAMMA Investing LLC now owns 1,126 shares of the semiconductor company’s stock worth $127,000 after purchasing an additional 562 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of Silicon Laboratories by 72.2% during the first quarter. Principal Financial Group Inc. now owns 129,911 shares of the semiconductor company’s stock worth $14,624,000 after purchasing an additional 54,463 shares in the last quarter. KBC Group NV increased its stake in shares of Silicon Laboratories by 27.1% during the first quarter. KBC Group NV now owns 1,625 shares of the semiconductor company’s stock worth $183,000 after purchasing an additional 346 shares in the last quarter. Oppenheimer Asset Management Inc. increased its stake in shares of Silicon Laboratories by 2.9% during the first quarter. Oppenheimer Asset Management Inc. now owns 7,379 shares of the semiconductor company’s stock worth $831,000 after purchasing an additional 210 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of Silicon Laboratories by 17.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,751 shares of the semiconductor company’s stock worth $310,000 after purchasing an additional 417 shares in the last quarter.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. KeyCorp upped their price objective on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an “overweight” rating in a research note on Tuesday, July 8th. Susquehanna upped their price objective on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a “neutral” rating in a research note on Tuesday, July 22nd. Barclays upped their price objective on shares of Silicon Laboratories from $100.00 to $130.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Silicon Laboratories in a research note on Saturday. Finally, Stifel Nicolaus upped their price objective on shares of Silicon Laboratories from $144.00 to $160.00 and gave the company a “buy” rating in a research note on Friday, July 18th. Five analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Silicon Laboratories currently has a consensus rating of “Hold” and a consensus target price of $151.13.

Silicon Laboratories Price Performance

Silicon Laboratories stock opened at $135.12 on Friday. The firm has a 50 day simple moving average of $134.39 and a 200-day simple moving average of $129.10. Silicon Laboratories, Inc. has a 1-year low of $82.82 and a 1-year high of $160.00. The stock has a market cap of $4.43 billion, a price-to-earnings ratio of -41.96 and a beta of 1.51.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business had revenue of $192.85 million during the quarter, compared to analysts’ expectations of $192.57 million. During the same quarter in the prior year, the company posted ($0.56) EPS. The business’s revenue for the quarter was up 32.6% on a year-over-year basis. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Equities analysts expect that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current fiscal year.

Insider Transactions at Silicon Laboratories

In other Silicon Laboratories news, SVP Brandon Tolany sold 1,800 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $133.57, for a total value of $240,426.00. Following the sale, the senior vice president owned 62,328 shares of the company’s stock, valued at $8,325,150.96. The trade was a 2.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold a total of 12,070 shares of company stock valued at $1,703,472 over the last 90 days. 1.60% of the stock is owned by insiders.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.